Have any questions? 706-721-6582 or cts@augusta.edu
This is a study involving advanced solid tumors and cervical cancer. The study is being done to test AGEN2034 as an immune therapy that targets a patient's immune cells to block a receptor called PD-1. This therapy is designed to improve the ability of the patient's immune system to fight cancer.